BiotechTube
Home/Pipeline/New Generic Approvals

New Generic Approvals

Various

Application Submitted / BE StageRegulatory Review

Key Facts

Indication
Various
Phase
Application Submitted / BE Stage
Status
Regulatory Review
Company
China SXT Pharmaceuticals

About China SXT Pharmaceuticals

China SXT Pharmaceuticals (NASDAQ: SXTC) is a China-based specialty pharmaceutical company with a dual-mission to modernize Traditional Chinese Medicine (TCM) and produce generic drugs. The company has established an integrated operational model, managing R&D, manufacturing, and commercialization in-house, primarily targeting high-prevalence conditions in its domestic market. Its strategy hinges on capitalizing on government support for TCM integration into the healthcare system and the ongoing demand for affordable generic pharmaceuticals, though it faces significant execution and competitive risks.

View full company profile

Therapeutic Areas

CardiovascularCentral Nervous SystemDigestiveMetabolic

Other Various Drugs

DrugCompanyPhase
New Dosage Form DevelopmentUniverse PharmaceuticalsDevelopment
New TCM Formula RegistrationUniverse PharmaceuticalsDevelopment
Bag APIsChemWerthApproved
Oral APIsChemWerthApproved
Companion Diagnostics DevelopmentKiffik BiomedicalPre-clinical
Portfolio of Complex Generics & 505(b)(2) ProductsAlvogenApproved/Commercial
Portfolio of 40+ productsPraxgen PharmaceuticalsDevelopment
Generic Product PipelineLannettANDA Development
Drug Repositioning ServiceBiovistaService
Custom Control DevelopmentAnchor MolecularDevelopment/Commercial
Portfolio from Steriscience PartnershipArmas PharmaceuticalsANDA Development/Filing
Generic Medicinal Products DevelopmentBasic PharmaCommercial